These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 17562797)
1. New guinea pig model of Cryptococcal meningitis. Kirkpatrick WR; Najvar LK; Bocanegra R; Patterson TF; Graybill JR Antimicrob Agents Chemother; 2007 Aug; 51(8):3011-3. PubMed ID: 17562797 [TBL] [Abstract][Full Text] [Related]
2. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774 [TBL] [Abstract][Full Text] [Related]
3. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease. Friese G; Discher T; Füssle R; Schmalreck A; Lohmeyer J AIDS; 2001 Nov; 15(17):2344-5. PubMed ID: 11698718 [No Abstract] [Full Text] [Related]
4. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole. Chang WN; Huang CR; Lei CB; Lee PY; Chien CC; Chang HW; Chang CS; Lu CH Jpn J Infect Dis; 2004 Jun; 57(3):113-5. PubMed ID: 15218221 [TBL] [Abstract][Full Text] [Related]
5. Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis. Shoji H; Takuma T; Ohbayashi H; Yoshida K; Yamamoto T; Niki Y J Infect Chemother; 2012 Oct; 18(5):775-9. PubMed ID: 22318291 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans. Perfect JR; Cox GM; Dodge RK; Schell WA Antimicrob Agents Chemother; 1996 Aug; 40(8):1910-3. PubMed ID: 8843302 [TBL] [Abstract][Full Text] [Related]
7. Cryptococcal meningitis in an immunocompetent child. Shinjoh M; Miyairi I; Sakurai M; Takahashi M; Ariyasu D; Nakayama T; Tokumura M; Yamashita R; Sunakawa K; Takahashi T Eur J Pediatr; 2005 Sep; 164(9):596-7. PubMed ID: 15959803 [No Abstract] [Full Text] [Related]
8. Fluconazole penetration into the prostatic fluid of patients with AIDS-associated cryptococcal meningitis. Luzzati R; Gatti G; Lazzarini L; Limonta D; Vento S; Concia E J Antimicrob Chemother; 1998 Mar; 41(3):423-4. PubMed ID: 9578176 [No Abstract] [Full Text] [Related]
9. Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure. Sabbatani S; Manfredi R; Pavoni M; Consales A; Chiodo F Mycopathologia; 2004 Aug; 158(2):165-71. PubMed ID: 15518344 [TBL] [Abstract][Full Text] [Related]
10. Clinical and laboratory features of cryptococcal meningitis in HIV-AIDS patients. Deo S J Assoc Physicians India; 1995 Oct; 43(10):724. PubMed ID: 8773019 [No Abstract] [Full Text] [Related]
11. Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis. Gazzoni AF; Capilla J; Mayayo E; Guarro J Int J Antimicrob Agents; 2012 Mar; 39(3):223-7. PubMed ID: 22226648 [TBL] [Abstract][Full Text] [Related]
12. Voriconazole inhibition of tacrolimus metabolism in a kidney transplant recipient with fluconazole-resistant cryptococcal meningitis. Chang HH; Lee NY; Ko WC; Lee HC; Yang YH; Wu CJ; Chang CM Int J Infect Dis; 2010 Apr; 14(4):e348-50. PubMed ID: 19665407 [TBL] [Abstract][Full Text] [Related]
13. A case of fluconazole, voriconazole-resistant Cryptococcus neoformans isolated from and immunocompetent patient. Mandras N; Roana J; Tullio V; Allizond V; Banche G; Scalas D; Fucale G; Cuffini AM J Chemother; 2011 Dec; 23(6):379-80. PubMed ID: 22233828 [No Abstract] [Full Text] [Related]
14. Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis. Wirth F; de Azevedo MI; Pilla C; Aquino VR; Neto GW; Goldani LZ Med Mycol; 2018 Apr; 56(3):257-262. PubMed ID: 28992308 [TBL] [Abstract][Full Text] [Related]
15. Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome. Kartalija M; Kaye K; Tureen JH; Liu Q; Täuber MG; Elliott BR; Sande MA J Infect Dis; 1996 May; 173(5):1216-21. PubMed ID: 8627075 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans. Miller JL; Schell WA; Wills EA; Toffaletti DL; Boyce M; Benjamin DK; Bartroli J; Perfect JR Antimicrob Agents Chemother; 2004 Feb; 48(2):384-7. PubMed ID: 14742184 [TBL] [Abstract][Full Text] [Related]
17. Comparison of D0870 and fluconazole in the treatment of murine cryptococcal meningitis. Correa AL; Velez G; Albert M; Luther M; Rinaldi MG; Graybill JR J Med Vet Mycol; 1995; 33(6):367-74. PubMed ID: 8683404 [TBL] [Abstract][Full Text] [Related]
18. [Cryptococcal meningitis successfully treated with liposomal amphotericin B and voriconazole in an elderly patient]. Ogaki K; Noda K; Fukae J; Furuya T; Hirayama T; Fujishima K; Hattori N; Okuma Y Brain Nerve; 2010 Dec; 62(12):1337-40. PubMed ID: 21139187 [TBL] [Abstract][Full Text] [Related]
19. Meningitis due to Cryptococcus neoformans: treatment with posaconazole. Flores VG; Tovar RM; Zaldivar PG; Martinez EA Curr HIV Res; 2012 Oct; 10(7):620-3. PubMed ID: 22873639 [TBL] [Abstract][Full Text] [Related]
20. Treatment of murine cryptococcal meningitis with UR-9751 and UR-9746. Restrepo MI; Najvar LK; Barchiesi F; Luther MF; Graybill JR Med Mycol; 2000 Jun; 38(3):221-4. PubMed ID: 10892990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]